The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hilton, C. J.
Right arrow Articles by Rock, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hilton, C. J.
Right arrow Articles by Rock, K. L.
The Journal of Immunology, 2001, 166: 3952-3956.
Copyright © 2001 by The American Association of Immunologists

Anti-Peptide Antibody Blocks Peptide Binding to MHC Class I Molecules in the Endoplasmic Reticulum1

Craig J. Hilton*, Astrid M. Dahl{dagger} and Kenneth L. Rock2,*

* Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01655; and {dagger} Department of Pathology, Brigham and Womans Hospital, Boston, MA 02115

The finding that MHC class I molecules are physically associated with the TAP transporter has suggested that peptides may be directly transported into the binding groove of the class I molecules rather than into the lumen of the endoplasmic reticulum (ER) where they subsequently would encounter class I molecules by diffusion. Such a mechanism would protect peptides from peptidases in the ER and/or escaping back into the cytoplasm. However, we find that an anti-peptide Ab that is cotranslationally transported into the ER prevents TAP-transported peptides from being presented on class I molecules. The Ab only blocks the binding of its cognate peptide (SIINFEKL) but not other peptides (KVVRFKDL, ASNENMETM, and FAPGNYPAL). Therefore, most TAP-transported peptides must diffuse through the lumen of the ER before binding stably to MHC class I molecules.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Margalit, H. M. Sheikhet, Y. Carmi, D. Berko, E. Tzehoval, L. Eisenbach, and G. Gross
Induction of Antitumor Immunity by CTL Epitopes Genetically Linked to Membrane-Anchored {beta}2-Microglobulin
J. Immunol., January 1, 2006; 176(1): 217 - 224.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Shen and K. L. Rock
Cellular protein is the source of cross-priming antigen in vivo
PNAS, March 2, 2004; 101(9): 3035 - 3040.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Lankat-Buttgereit and R. Tampe
The Transporter Associated With Antigen Processing: Function and Implications in Human Diseases
Physiol Rev, January 1, 2002; 82(1): 187 - 204.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.